ARTICLE | Company News
Applied Immune Sciences Inc. other research news
September 7, 1993 7:00 AM UTC
AISX received $850,000 from two Phase II SBIR's. A $456,900 three-year SBIR from the National Heart, Lung and Blood Institute will fund development of methods to simplify and increase the capacity of ...